Trials / Completed
CompletedNCT00793806
Immunologic Abnormalities, Chronic Inflammation and Oxidative Stress in Chronic Kidney Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 14 (actual)
- Sponsor
- University of California, Irvine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The common causes of mortality are late stages of chronic kidney disease, cardiovascular disease and infections, are associated with abnormalities of the immune system, an underlying state of chronic inflammation and oxidative stress. These processes have not been carefully described in the chronic kidney disease population. The researcher can use Diffuse Optical Spectroscopy to determine the immune system in individuals with chronic kidney disease and describe the association with chronic inflammation and oxidative stress in that population.
Detailed description
The Diffuse Optical Spectroscopy can measure the absolute concentrations of reduced and oxygenated hemoglobins,cardiac output, mean arterial pressure, blood loss,blood hemoglobin concentration, water and lipid concentrations of the tissue. The researchers can use Diffuse Optical Spectroscopy to monitor volume changes during the hemodialysis treatment and to correlate the changes in volume and blood pressure with the measures of oxidative stress and inflammation used in this study. The researchers can use Diffuse Optical Spectroscopy data to compare to laboratory parameters routinely measured to clinical parameters such as cause of chronic kidney disease, blood pressure and dialysis-related parameters.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Diffuse Optical Spectroscopy | Diffuse Optical Spectroscopy measurements will be compared to a variety of laboratory parameters routinely measured in Chronic Inflammation and Oxidative Stress in Chronic Kidney Disease |
Timeline
- Start date
- 2008-08-01
- Primary completion
- 2012-03-01
- Completion
- 2012-03-01
- First posted
- 2008-11-19
- Last updated
- 2022-10-20
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00793806. Inclusion in this directory is not an endorsement.